• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last half-hour
In the last 2 hours
In the last 4 hours
In the last 6 hours
In the last 8 hours
Earlier today
Yesterday
Diabetes drug may reduce colorectal cancer risk Knowridge Science Report22:54 2-Mar-24
Medicine shortages up by 20 per cent in a year Belga News Agency10:48 2-Mar-24
In the last 7 days
Why Hormel Foods Shot Up 16% This Week The Motley Fool20:44 1-Mar-24
Queen Oprah As Weight-Loss Disruptor MediaPost17:29 1-Mar-24
Oprah is leaving Weight Watchers KCRG TV 9, Iowa17:03 1-Mar-24
Kylie Jenner used Ozempic for weight loss? The News International00:20 1-Mar-24
Obesity cost US businesses $425.5bn in 2023 Pharmaceutical Technology16:48 29-Feb-24
view more headlines
3 Mar 11:45

About our Semaglutide news

Latest news on semaglutide, a medication used for the treatment of type 2 diabetes. It works by mimicking the action of a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1), which stimulates the production of insulin and helps regulate blood sugar levels. In addition to its effects on blood sugar, semaglutide can also help with weight loss and has been approved for this purpose under the brand name Wegovy. It is also sold under the brand names Ozempic and Rybelsus.

Wegovy is a medication used for weight management in adults who are overweight or have obesity and at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol. It contains the drug semaglutide, which mimics the action of a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1). GLP-1 stimulates insulin production and helps regulate blood sugar levels, and it also helps reduce appetite and increase feelings of fullness.

Wegovy is administered by injection once a week, and it has been shown in clinical trials to lead to significant weight loss in overweight and obese individuals. It is not intended as a standalone treatment for weight loss but should be used in conjunction with a healthy diet and regular exercise. Additionally, Wegovy has potential side effects, and it should only be used under the guidance of a healthcare provider.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.